| Stage | USPH | % of rev | PRVA | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $214M | 100.00% | $633M | 100.00% | PRVA ×2.96 |
| Gross profit | $87M | 40.43% | $563M | 89.04% | PRVA +48.6pp |
| Operating income | $22M | 10.25% | $12M | 1.86% | USPH +8.4pp |
| Pre-tax income | $19M | 8.90% | $17M | 2.65% | USPH +6.3pp |
| Net income | $15M | 6.96% | $10M | 1.54% | USPH +5.4pp |
| Stage | USPH | PRVA | Gap · A − B |
|---|---|---|---|
| Revenue | $214M100.00% | $633M100.00% | PRVA ×2.96 |
| Gross profit | 40.43%$87M | 89.04%$563M | PRVA +48.6pp |
| Operating income | 10.25%$22M | 1.86%$12M | USPH +8.4pp |
| Pre-tax income | 8.90%$19M | 2.65%$17M | USPH +6.3pp |
| Net income |
| 6.96%$15M |
| 1.54%$10M |
| USPH +5.4pp |
No shared counterparties.